Abstract:Objective To evaluate the efficacy and safety of intravitreal injection of Bevacizumab (Avastin) combined with laser photocoagulation in the patients of macular edema secondary to retinal vein occlusion (RVO).Methods This was a retrospective cases-series study.Thirty eyes of 30 RVO patients (branch RVO 20 eyes and central RVO 10 eyes) were erolled,aged from 34 to 79,with average of (57.3±8.9)years.The eyes were treated with intravitreal injections of Bevacizumab (1.25 mg) combined with laser photocoagulation.The treatment method of intravitreal injection had been conducted according to PrONTO study.Best corrected visual acuity (BCVA,ETDRS letters),fundus photography,optical coherence tomography (OCT) were committed at baseline and 1,3,6,12 months after intravitreal injection.The ETDRS letters and the central retinal thickness (CRT) by OCT were recorded.Changes in BCVA and CRT measurements from baseline at the various follow-up endpoints were assessed with paired t test.Spearman correlation coefficient was used to measure the strength of correlation between BCVA and anatomic changes.Results The mean number of the injections in the 30 patients was 3.9±1.9.The BCVA improved 3 or more lines in 16 eyes (54％),improved 1 to 2 lines in 10 eyes (33％),stabilized (±1 line or no change) in 4 eyes (13％) and none decreased.The average BCVA at baseline was (42±19) letters,and improved to (60±19) letters at 12 months (t=7.87,P＜0.05).The average of retinal thickness of macular foveal decreased from (616.7±177.0)μm at baseline to (268.9±l15.9)μm at 12 months (t=13.23,P＜0.05).BCVA 12 months post-treatment was correlated to BCVA pre-treatment (r=0.791,P＜0.01).Macular edema had no correlation with baseline and finally BCVA.21 eyes (70％) showed no observed macular edema by the last follow-up and the side effects were not observed during the follow-up.Conclusion The persistent and rebound macular edema found in Bevacizumab treatment had some common characteristics in FFA. Combined intravitreal injections of Bevacizumab and laser photocoagulation therapy seemed to be effective for managing some refractory macular edema secondary to RVO.The Bevacizumab and photocoagulation related adverse events are rare.

Predictors of Short- Term Outcomes Related to Central Subfield Foveal Thickness after Intravitreal Bevacizumab for Macular Edema Due to Central Retinal Vein Occlusion

Retinal Microstructure Based on Optical Coherence Tomography Predicts Visual Prognosis in Diabetic Macular Edema with Extended Intraretinal Cysts and Subretinal Fluid.

Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema.

Predictive Factors for Functional and Anatomical Outcomes After Anti-VEGF Treatment for Macular Edema in Patients with Branch Retinal Vein Occlusion

Clinical study on intravitreous injection of Avastin for macular edema induced by central retinal vein occlusion

Choroidal thickness as a possible predictor of non-response to intravitreal bevacizumab for macular edema after retinal vein occlusion

Predictors of Visual and Anatomical Outcomes for Neovascular Age-Related Macular Degeneration Treated with Bevacizumab

Analyze of Factors and Prognosis of Eyes Lost to Follow-Up in Retinal Vein Occlusive Disease Patients Receiving Anti-Vascular Endothelial Growth Factor Therapy

Choroidal Response to Intravitreal Bevacizumab Injections in Treatment-Naïve Macular Neovascularization Secondary to Chronic Central Serous Chorioretinopathy

Intravitreal Bevacizumab Treatment for Branch Retinal Vein Occlusion Accompanied by Macular Edema

Short-term effects of anti-VEGF drugs on macular perfusion in patients with diabetic macular edema

Macular Edema Patterns and Response to Intravitreal Avastin Therapy in Branch Retinal Vein Occlusion

Evaluation of the Vascular Density, the Area of Foveal Avascular Zone, and Corrected Vision in Patients with Diabetic Macular Edema after Anti-VEGF Therapy

Subfoveal Choroidal Thickness and Treatment Outcomes of Intravitreal Aflibercept for Branch Retinal Vein Occlusion

Comparison of Choroidal Thickness, Foveal Avascular Zone, and Macular Capillary Density in Macular Edema Secondary to Branch Retinal Vein Occlusion Treated with Ranibizumab or Aflibercept—A Prospective Study

Clinical Observation of Intravitreal Bevacizumab Combined with Laser Photocoagulation for Treatment of Macular Edema Secondary to Retinal Vein Occlusion

Central retinal thickness changes and risk of neovascular glaucoma after intravitreal bevacizumab injection in patients with central retinal vein occlusion

The clinical study on intravitreous injection of avastin for macular edema induced by branch retinal vein occlusion

Bevacizumab Treatment for Acute Branch Retinal Vein Occlusion Accompanied by Subretinal Hemorrhage.

Changes in Aqueous Concentrations of Various Cytokines after Intravitreal Bevacizumab Injection for Chronic Central Serous Chorioretinopathy

A real-world study for timely assessing the diabetic macular edema refractory to intravitreal anti-VEGF treatment